Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement
Authors:
- Donald M. Lloyd-JonesDLDonald M. Lloyd-Jones
- Aaron BaggishABAaron Baggish
- Annabel ChenACAnnabel Chen
- Daniel KrauserDKDaniel Krauser
- Roderick TungRTRoderick Tung
- Claudia ChaeCCClaudia Chae
- James L. JanuzziJJJames L. Januzzi
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) studyThe American Journal of Cardiology, 2005
- Elimination of the Cardiac Natriuretic Peptides B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP by HemodialysisClinical Chemistry, 2004
- Renal Insufficiency and Heart FailureCirculation, 2004
- Diagnosis of heart failure using urinary natriuretic peptidesClinical Science, 2004
- Kidney Disease as a Risk Factor for Development of Cardiovascular DiseaseHypertension, 2003
- The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosisEuropean Heart Journal, 2003
- The Prognostic Role of Brain Natriuretic Peptides in Hemodialysis PatientsAmerican Journal of Nephrology, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Plasma brain natriuretic peptide levels in chronic hemodialysis patients: Influence of coronary artery diseaseAmerican Journal of Kidney Diseases, 2001
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997